Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.55 |
| ▸ | ANPEP | P15144 | 1/20 | 0.52 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.41 |
| ▸ | GSR | P00390 | 2/20 | 0.41 |
| ▸ | GRM8 | O00222 | 1/20 | 0.41 |
| ▸ | GRM6 | O15303 | 1/20 | 0.41 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.41 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.41 |
| ▸ | GRM5 | P41594 | 1/20 | 0.41 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.41 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.41 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL384886 | 1.00 | DPP7 (0.55) | DPP7ANPEPERAP2KMT2AMEN1 | |
| SCHEMBL1176730 | 1.00 | DPP7 (0.55) | DPP7ANPEPERAP2KMT2AMEN1 | |
| Hydrochloric Acid SCHEMBL31323997 | 0.98 | DPP7 (0.53) | DPP7ANPEPERAP2KMT2AMEN1 | |
| SCHEMBL25661087 | 0.98 | DPP7 (0.52) | DPP7ANPEPERAP2KMT2AMEN1 | |
| SCHEMBL5322593 | 0.98 | DPP7 (0.52) | DPP7ANPEPERAP2KMT2AMEN1 | |
| SCHEMBL4637391 | 0.83 | ANPEP (0.52) | DPP7ANPEPERAP2KMT2AMEN1 | |
| SCHEMBL15049655 | 0.81 | ALDH1A1 (0.61) | DPP7ANPEPKMT2AMEN1MAPT | |
| SCHEMBL1527303 | 0.81 | DPP7 (0.53) | DPP7ANPEPERAP2KMT2AL3MBTL1 | |
| SCHEMBL1527306 | 0.81 | DPP7 (0.53) | DPP7ANPEPERAP2KMT2AL3MBTL1 | |
| SCHEMBL5533637 | 0.81 | ALDH1A1 (0.61) | DPP7ANPEPKMT2AMEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050119190-A1 | Inhibitors of the blood-clotting factor xa, production thereof and use of the same | CURACYTE AG (DE) | 2005-06-02 | — | — | US | claimed |
| US-8148430-B2 | Process for the hydrogenation of aromatic compounds | EVONIK DEGUSSA GMBH (DE) | 2012-04-03 | — | — | US | disclosed |
| US-20050119190-A1 | Inhibitors of the blood-clotting factor xa, production thereof and use of the same | CURACYTE AG (DE) | 2005-06-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050119190-A1 | Inhibitors of the blood-clotting factor xa, production thereof and use of the same | SERPINC1, TFPI, F11 | DPP7 349/4885ANPEP 151/4885ERAP2 607/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.